What Has Been The Evolution of the Cell Expansion Market in Recent Years?
The cell expansion market has seen considerable growth due to a variety of factors.
• The market size for cell expansion has significantly increased in the past few years. Its growth is projected to rise from $28.11 billion in 2024 to an estimated $32.22 billion in 2025, with a compound annual growth rate (CAGR) of 14.6%. Factors contributing to the growth during the historic period include increased public awareness and acceptance, applications of cell-based research, a surge in the demand for cell-based therapies, growth in the biopharmaceutical industry, and advancements in regenerative medicine.
How Will the Cell Expansion Market Size Evolve over the Forecast Period?
The Cell Expansion market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for the cell expansion market size to experience a swift surge in growth in the coming years. With a projected compound annual growth rate (CAGR) of 16.4%.
, it is anticipated to reach $59.14 billion by 2029. Factors such as increased funding in biotechnology, growth in stem cell research, clinical tests and drug development, as well as a demand for personalized medicine, biobanking, and cell repositories, are all contributing to this anticipated growth within the forecast period. Key trends expected during this period include advancements in technology, product innovation, and strategic partnerships.
Which Factors Are Boosting Growth In The Cell Expansion Market?
The demand for the cell expansion market is anticipated to grow due to the rising prevalence of chronic diseases. These diseases typically persist over a long period and are often incurable, though sometimes controllable. Table use, insufficient nourishment, physical inactivity, extensive alcohol consumption, among others, contribute to the rise in chronic diseases. Cell expansion helps in the restoration of nutrients and prevents the accumulation of harmful metabolic waste that could affect culture effectiveness. For instance, data from the US-based National Library of Medicine, the National Center for Biotechnology Information (NCBI), projected that by 2050, the population aged 50 years and above with at least one chronic disease will skyrocket by 99.5%, from 71.522 million in 2020 to 142.66 million. Consequently, the escalating incidence of chronic diseases is set to fuel the expansion of the cell expansion market.
What Key Areas Define The Segmentation Of The Global Cell Expansion Market?
The cell expansion market covered in this report is segmented –
1) By Cell Type: Mammalian, Microbial, Other Cell Types
2) By Product: Consumables, Reagents, Media, Serum, Disposables, Instruments
3) By Application: Biopharmaceuticals, Tissue Culture And Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Other Applications
4) By End-user: Biopharmaceutical And Biotechnology Companies, Research Institutes, Cell Banks, Other End-Users
Subsegments:
1) By Mammalian: Adherent Cells, Suspension Cells, Stem Cells
2) By Microbial: Bacterial Cells, Yeast Cells, Fungal Cells
3) By Other Cell Types: Plant Cells, Insect Cells, Hybridoma Cells
Pre-Book The Cell Expansion Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Cell Expansion Market?
Prime players in the cell expansion market are highlighting the importance of innovations in bioprocessing technologies, such as automatic 3D bioreactor systems, to amplify the effectiveness and scalability of cell production for medicinal usage. PluriCDMO is a division that uses a unique 3D bioreactor system for large-scale, automated cell therapy manufacturing, ensuring steady, superior production from initial development to clinical trials. As an example, in January 2024, Pluristem Therapeutics Inc., a leading biotechnology firm from Israel, introduced a fresh business unit, PluriCDMO that will facilitate cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). The novel division comprises a 47,000-ft2, good manufacturing practice (GMP) cell therapy production facility. With this newly established division, Pluri will extend services from early preclinical development to late-stage clinical trials and commercialization.
Who Are the Key Players In The Cell Expansion Market?
Major companies operating in the cell expansion market include:
• Thermo Fisher Scientific Inc.
• Becton Dickinson and Company
• Lonza Group
• Corning Inc.
• Merck KGaA
• Sartorius Stedim Biotech SA
• Terumo Corporation
• Miltenyi Biotec GmbH
• Danaher Corporation
• Stemcell Technologies Inc.
• Beckman Coulter Inc.
• Takara Bio Inc.
• RepliCel Life Sciences
• Neximmune Inc.
• Celltainer Biotech BV
• GE HealthCare Technologies Inc.
• ReproCELL USA Inc.
• iXCells Biotechnologies Inc.
• Neuromics LLC
• G&G Technologies Inc.
• Eppendorf AG
• Avantor Inc.
• Bio-Techne Corporation
• BioLife Solutions Inc.
• Cesca Therapeutics Inc.
• Core Dynamics Ltd.
• Lifeline Scientific Inc.
• Princeton Cryotech Inc.
• VWR International LLC
• Azenta US Inc.
• MVE Biological Solutions LLC
• BioCision LLC
• BioSpherix Ltd.
• Worthington Industries Inc.
What Is The Most Dominant Region In The Cell Expansion Market?
North America was the largest region in the cell expansion market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
